Liao Xinyuan, Zhuang Xingxing, Liang Chenghui, Li Jinyu, Flaumenhaft Robert, Yuan Cai, Huang Mingdong
College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, China.
College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China.
J Agric Food Chem. 2022 Apr 13;70(14):4475-4483. doi: 10.1021/acs.jafc.1c07994. Epub 2022 Apr 4.
Quercetin-3-rutinoside (rutin) is a bioflavonoid that is common in foods. The finding that quercetin-3-rutinoside inhibits protein disulfide isomerase (PDI) and potently blocks thrombosis has enabled the evaluation of PDI inhibition in multiple animal models of thrombus formation and has prompted clinical studies of PDI inhibition in thrombosis. Nonetheless, how quercetin-3-rutinoside blocks PDI activity remains an unanswered question. Combining NMR spectroscopy, site-directed mutagenesis, and biological assays, we identified H256 as the key residue for PDI interacting with quercetin-3-rutinoside. Quercetin-3-rutinoside inhibited the activity of PDI (WT) but not PDI (H256A). Molecular dynamic simulations indicated that the flavonoid skeleton, but not the rutinoside conjugate, is embedded in the major binding pocket on the b' domain. Among several quercetin-3-rutinoside analogues tested, only compounds with a phenoxyl group at position 7 showed direct binding to PDI, further supporting our molecular model. Studies using purified coagulation factors showed that quercetin-3-rutinoside inhibited the augmenting effects of PDI (WT), but not PDI (H256A), on tissue factor (TF) activity. Quercetin-3-rutinoside also inhibited chemotherapy-induced TF activity enhancement on endothelial cells. Together, our studies show that residue H256 in PDI and the phenoxyl group at position 7 in quercetin-3-rutinoside are essential for inhibition of PDI by quercetin-3-rutinoside. These results provide new insight into the molecular mechanism by which flavonoids block PDI activity.
槲皮素-3-芸香糖苷(芦丁)是一种常见于食物中的生物类黄酮。槲皮素-3-芸香糖苷可抑制蛋白质二硫键异构酶(PDI)并有效阻止血栓形成,这一发现使得在多种血栓形成动物模型中对PDI抑制作用进行评估成为可能,并促使开展了关于PDI抑制在血栓形成方面的临床研究。尽管如此,槲皮素-3-芸香糖苷如何阻断PDI活性仍是一个未解之谜。通过结合核磁共振光谱、定点诱变和生物学检测,我们确定H256是PDI与槲皮素-3-芸香糖苷相互作用的关键残基。槲皮素-3-芸香糖苷抑制了PDI(野生型)的活性,但对PDI(H256A)没有抑制作用。分子动力学模拟表明,类黄酮骨架而非芸香糖苷共轭物嵌入了b'结构域的主要结合口袋中。在所测试的几种槲皮素-3-芸香糖苷类似物中,只有7位带有苯氧基的化合物显示出与PDI的直接结合,这进一步支持了我们的分子模型。使用纯化凝血因子的研究表明,槲皮素-3-芸香糖苷抑制了PDI(野生型)而非PDI(H256A)对组织因子(TF)活性的增强作用。槲皮素-3-芸香糖苷还抑制了化疗诱导的内皮细胞TF活性增强。总之,我们的研究表明,PDI中的残基H256以及槲皮素-3-芸香糖苷7位的苯氧基对于槲皮素-3-芸香糖苷抑制PDI至关重要。这些结果为黄酮类化合物阻断PDI活性的分子机制提供了新的见解。